Illumina ILMN

Jump To Section

    $

    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    .
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    -$1.32 (-1.21%)Past DayToday's Volume:
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    ,
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0

    Relative Strength Index (RSI)

    - The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

    - The RSI is calculated using the following formula:

    RSI = 100 - (100 / (1 + RS))

    Where RS is the ratio of the average gains to the average losses over a specified period.

    - The default time period used is 14 days.

    - RSI values range between 0 and 100.

    RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

    RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

    RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

    About

    Illumina (ILMN) Business Model and Operations Summary
    Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.

    Key Insights

    Illumina (ILMN) Core Market Data and Business Metrics
    • Latest Closing Price

      $108.71
    • Market Cap

      $11.29 Billion
    • Average Daily Volume

      2,666,875 Shares
    • 52-Week Range

      $68.70-$156.66
    • Price-Earnings Ratio

      -17.91
    • Total Outstanding Shares

      158.30 Million Shares
    • CEO

      Mr. Jacob Thaysen Ph.D.
    • Total Employees

      8,970
    • Current Dividend

      No dividend
    • IPO Date

      July 28, 2000
    • SIC Description

      Laboratory Analytical Instruments
    • Headquarters

      5200 Illumina Way, San Diego, CA, 92122

    Earnings Reports

    Expected vs. Actual Quarterly Earnings-Per-Share & Revenue

    Short Volume

    Daily short volume activity identifies short-term trading pressure and potential price volatility

    Short Interest

    Bi-monthly short interest levels can be used to gauge bearish market sentiment and short squeeze potential

    Revenue Breakdown

    Distribution of revenue across unique business segments & geographies

    Cash Flow Statement

    March 31, 2024 to March 30, 2025

    Income Statement

    March 31, 2024 to March 30, 2025

    Comprehensive Income

    March 31, 2024 to March 30, 2025

    Balance Sheet

    March 31, 2024 to March 30, 2025

    Historical Stock Splits

    If you bought 1 share of ILMN before September 23, 2008, you'd have 2 shares today

    Historical Dividends

    Recent Headlines From The Web

    Latest news, press releases, and media coverage about ILMN from trusted financial sources

    Related Companies

    Publicly traded companies similar to Illumina (ILMN)
    Boost your savings and earn 3.95% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.